Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Clinical trial NCT00037791 · COMPLETED

Trial details

NCT number: NCT00037791
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms Thrombocytopenia Multiple Myeloma Lymphoma, Malignant

Start date: 1999-12-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.